TY - JOUR
T1 - Monoclonal Anti-AMP Antibodies Are Sensitive and Valuable Tools for Detecting Patterns of AMPylation
AU - Höpfner, Dorothea
AU - Fauser, Joel
AU - Kaspers, Marietta S.
AU - Pett, Christian
AU - Hedberg, Christian
AU - Itzen, Aymelt
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020/12/18
Y1 - 2020/12/18
N2 - AMPylation is a post-translational modification that modifies amino acid side chains with adenosine monophosphate (AMP). Recently, a role of AMPylation as a universal regulatory mechanism in infection and cellular homeostasis has emerged, driving the demand for universal tools to study this modification. Here, we describe three monoclonal anti-AMP antibodies (mAbs) from mouse that are capable of protein backbone-independent recognition of AMPylation, in denatured (western blot) as well as native (ELISA, IP) applications, thereby outperforming previously reported tools. These antibodies are highly sensitive and specific for AMP modifications, highlighting their potential as tools for new target identification, as well as for validation of known targets. Interestingly, applying the anti-AMP mAbs to various cancer cell lines reveals a previously undescribed broad and diverse AMPylation pattern. In conclusion, these anti-AMP mABs will further advance the current understanding of AMPylation and the spectrum of modified targets.
AB - AMPylation is a post-translational modification that modifies amino acid side chains with adenosine monophosphate (AMP). Recently, a role of AMPylation as a universal regulatory mechanism in infection and cellular homeostasis has emerged, driving the demand for universal tools to study this modification. Here, we describe three monoclonal anti-AMP antibodies (mAbs) from mouse that are capable of protein backbone-independent recognition of AMPylation, in denatured (western blot) as well as native (ELISA, IP) applications, thereby outperforming previously reported tools. These antibodies are highly sensitive and specific for AMP modifications, highlighting their potential as tools for new target identification, as well as for validation of known targets. Interestingly, applying the anti-AMP mAbs to various cancer cell lines reveals a previously undescribed broad and diverse AMPylation pattern. In conclusion, these anti-AMP mABs will further advance the current understanding of AMPylation and the spectrum of modified targets.
KW - Biochemistry
KW - Biomolecules
KW - Biotechnology
KW - Molecular Biology
UR - http://www.scopus.com/inward/record.url?scp=85097427255&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2020.101800
DO - 10.1016/j.isci.2020.101800
M3 - Article
AN - SCOPUS:85097427255
SN - 2589-0042
VL - 23
JO - iScience
JF - iScience
IS - 12
M1 - 101800
ER -